Slingshot members are tracking this event:
Immunomedics (IMMU) Expects Updated Phase 2 Results for IMMU-130 in Metastatic Colorectal Cancer in 1H 2016
Slingshot Insights Explained
Apr 18, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Updated Results, Phase 2 Data, Immu-130, Metastatic Colorectal Cancer, 1h 2016